NTNicola Thorp

Nicola Thorp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicola Thorp has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & Ireland

    by John Gaffney, Anna France, Romelie Rieu, Yuwei Wang, Aisling M. Glynn, Karlee Brown, Claire Rooney, Abby Thomas, Amanda Swan, Zainul Kapacee, et al.

  • Open Access

    Challenges of delivering bi-daily general anaesthetic for hyperfractionated accelerated proton beam therapy for high-risk medulloblastoma

    by Love Goyal, Natalie Blundell, Yen Ching Chang, Cathy Dunlea, Jenny Gains, Lucy Hartley, Henry Mandeville, Shermaine Pan, Elizabeth Pask, Ed Smith, et al.


  • Failure to Complete Proton Beam Therapy Relating to Problems With Anesthesia

    by Natalie Blundell, Love Goyal, Nicola Thorp, Lucy Hartley, Ed Smith

    Introduction: Proton beam therapy (PBT) is becoming the radiotherapeutic modality of choice for children with curable cancer. A significant proportion require anesthetic care to facilitate precise positioning and immobility, and such patients undergo repetitive episodes of general anesthesia, 5 days a week for up to 8 weeks. Patients with central nervous tumors and those undergoing concurrent chemotherapy form a large proportion of referrals. Although X‐ray therapy and PBT demonstrate similarities, factors including younger patient age, longer session length and a need for rigid immobilization, means that providing anesthetic care for PBT is more complex as compared to X‐ray therapy. We present a case series of three patients who failed to complete PBT due to problems relating to anaesthesia. Our objective is to highlight specific PBT‐related challenges in the pediatric population, because although serious complications are uncommon, there can still be significant risk. Methods: We retrospectively reviewed the patient records of the three pediatric cases that failed to complete PBT at our outpatient regional center between January 2020 and December 2022. Results: Two cases failed to complete PBT due to respiratory adverse events, including one that required admission to intensive care. Both of these cases had central nervous tumours. The third case developed neutropenic typhlitis relating to concurrent chemotherapy making the patient unfit for ongoing anesthesia. Discussion: All three cases demonstrate that the risk of adverse events cannot be reliably predicted in this patient group. Detailed assessment must be performed prior to proceeding with anesthesia including regular review of blood tests, observations, and examining patients for any signs and symptoms of subclinical infection. The decision to proceed with anesthesia on a daily basis will require an anesthetic team that is highly skilled and familiar with their environment. Conclusion: Anesthetic care for PBT is more complex as compared to X‐ray therapy. A small group of children, particularly those with central nervous system tumors or altered respiratory control, may be at increased and sometimes unpredictable risk. Safe and sustainable care for PBT is possible with careful history taking, planning, and identification of patients at a higher risk of adverse events.


  • Open Access

    Sustainable capital funding for modern and innovative radiotherapy services

    by Imogen Powell Brown, Daniel Hutton, Nicola Thorp, James Thomson, Ran MacKay, Liesl Hacker, Lisa Ashmore, John Hayes, John Archer, Carl Rowbottom

    Radiotherapy providers are dependent on capital investment in equipment, which makes up 62% of the cost of delivering radiotherapy. The commissioning of radiotherapy services and duty to replace equipment is currently held by NHS England, but this responsibility and funding will be delegated to all Integrated Care Boards (ICBs). With constraints in national health capital spend over the past decade leaving radiotherapy infrastructure depleted, ICBs are set to inherit an expensive task of updating and replacing radiotherapy equipment. The upcoming National Cancer Plan presents the opportunity for a long-term solution to the renewal and investment in radiotherapy equipment, through rolling ringfenced funding from Government.This paper is part of a series of three papers, on (1) radiotherapy tariff, (2) radiotherapy capital spending and (3) holistic aspects of radiotherapy funding, which together consider what a sustainable, innovative and person centred radiotherapy funding model looks like as specialised services are delegated to Integrated Care Boards.